Increased expression of the mRNA encoding the somatostatin receptor subtype five in human colorectal adenocarcinoma

Journal of Molecular Endocrinology

Volumn 24, Issue 3, 2000, Pages 397-408

  Vuaroqueaux, V ^a   Dutour, A ^a,b   Bourhim, N ^a   Ouafik, L 'H ^c   Monges, G ^d   Briard, N ^a   Sauze, N ^a   Oliver, C ^a,b   Grino, M ^a  

^a INSERM   (France)

^b HÔPITAL NORD   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; BINDING COMPETITION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONFERENCE PAPER; FEMALE; GENE EXPRESSION; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECTUM CARCINOMA; RNA ANALYSIS; TISSUE DISTRIBUTION;

EID: 0034122349     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0240397     Document Type: Conference Paper

References (53)

1. Aguila MC, Rodriguez AM, Aguila-Mansilla HN & Lee WT 1996 Somatostatin antisense oligonucleotide-mediated stimulation of lymphocyte proliferation in culture. Endocrinology 137 1585-1590.
2. Biagini P, Monges G, Vuaroqueaux V, Parriaux D, Cantaloube F & De Micco P 1997 The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines. Life Sciences 61 1009-1018.
3. Buscail L, Delesque N, Estè ve J-P, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N & Susini C 1994 Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proceedings of the National Academy of Sciences of the USA 91 2315-2319.
4. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, Kalthoff H, Lluis F, Vaysse N & Susini C 1996 Loss of sst2 receptor gene expression in human pancreatic and colorectal cancer. Cancer Research 56 1823-1827.
5. Cascinu S, Del Ferro E, Grianti C, Ligi M, Ghiselli R, Foglieti G, Saba V, Lungarotti F & Catalano G 1997 Inhibition of tumor cell kinetics and serum insulin growth factor I by octreotide in colorectal patients. Gastroenterology 113 767-772.
6. Casini C, Lattuada D, Perego C, Fransco P & Marelli O 1997 Inhibitory effect of somatostatin on human T lymphocytes proliferation. International Journal of Immunopharmacology 19 721-727.
7. Cordelier P, Estè ve J-P, Bousquet C, Delesque N, O'Carroll AM, Schally AV, Vaysse N, Susini C & Buscail L 1997 Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proceedings of the National Academy of Sciences of the USA 94 9343-9348.
8. Davies N, Kynaston H, Yates J, Nott DM, Nash J, Taylor BA & Jenkins SA 1995 Octreotide inhibits the growth and the development of three types of experimental liver metastases. British Journal of Surgery 82 840-843.
9. Delean A, Munson PJ & Rodbard D 1978 Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. American Journal of Physiology 235 E97-E102.
10. Dukes CE & Bussey HJR 1958 The spread of rectal cancer and its effect on prognosis. British Journal of Cancer 12 309-320.
11. Dutour A, Kumar U, Panetta R, Ouafik L'H, Fina F, Ramakrishnan S & Patel Y 1998 Expression of somatostatin receptor subtypes in human brain tumors. International Journal of Cancer 76 620-627.
12. Dy DY & Morris DL 1993 Somatostatin inhibits both in vivo and in vitro carcinoembryonic antigen secretion by human colon cancer. European Journal of Surgical Oncology 19 168-172.
13. Dy DY, Whitehead RH & Morris DL 1992 SMS 201-995 inhibits in vitro and in vivo growth of human colon cancer. Cancer Research 52 917-923.
14. Estève JP, Rochaix P, Voigt JJ, Serially AV, Vaysse N, Susini C & Buscail L 1998 Role of nitric oxide in the antiproliferative signal mediated by the somatostatin receptor sst5. Gastroenterology 114 G4651.
15. Fais S, Annibale B, Boirivant M, Santoro A, Pallone F & Delle Fave G 1991 Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocytes activation. Journal of Neuroimmunology 31 211-219.
16. Florio T & Schettini 1996 Multiple intracellular effectors modulate physiological function of the cloned somatostatin receptors. Journal of Molecular Endocrinology 17 89-100.
17. Florio T, Yao H, Carey KD, Dillon TJ & Stork PJS 1999 Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1. Molecular Endocrinology 13 24-37.
18. Goldberg RM, Moertel CG, Wiehand HS, Krook JE, Schutt AJ, Veeder MH, Milliard JA & Dalton R 1995 A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. Cancer 76 962-966.
19. Gouyon BA, Reyl-Desmars F, Le Romancer M, Pigeon C, Lewin MJM & Lehy T 1995 In vivo effect of somatostatin analogue, lantreotide, and/or GRP antagonist, BIM 26226, on the growth of colon cancer peritoneal carcinomatosis in the rat. International Journal of Oncology 7 1167-1173.
20. Grino M & Zamora AJ 1998 An in situ hybridization histochemistry technique allowing simultaneous visualization by the use of confocal microscopy of three cellular mRNA species in individual neurons. Journal of Histochemistry and Cytochemistry 46 753-759.
21. Hoefland LJ & Lambert SWJ 1996 Somatostatin receptors and disease: role of receptor subtypes. Baillière's Clinical Endocrinology and Metabolism 10 163-176.
22. Iftikhar SY, Watson SA & Morris DL 1991 The effect of long acting somatostatin analogue SMS 201-995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancer. British Journal of Cancer 63 971-974.
23. Iftikhar SY, Thomas WM, Rooney PS & Morris DL 1992 Somatostatin receptors in human colorectal cancer. European Journal of Surgical Oncology 18 27-30.
24. Krempels K, Hunyady B, O'Carroll AM & Mezey C 1997 Distribution of somatostatin receptors messenger RNAs in the gastrointestinal tract. Gastroenterology 112 1948-1960.
25. Lamberts SWJ, Krenning EP & Reubi JC 1991 The role of somatostatin receptors and its analogs in the diagnosis and treatment of tumors. Endocrine Reviews 12 450-482.
26. Laws S, Gough AC, Evans AA, Bains MA & Primerose JN 1997 Somatostatin receptors subtype mRNA expression in human colorectal cancer and normal colonic mucosa. British Journal of Cancer 75 360-366.
27. Lewin MJM 1992 The somatostatin receptor in the GI tract. Annual Review of Physiology 54 455-468.
28. Magnan E, Cataldi M, Guillaume V, Mazzochi L Dutour A, Compte Delvox B, Giraud P & Oliver C 1993 Neostigmine stimulates growth hormone-releasing hormone release into hypophysial portal blood of conscious sheep. Endocrinology 132 1247-1251.
29. Miller GV, Preston SR, Woodhouse LF, Farmery SM & Primerose JN 1993 Somatostatin binding in human gastrointestinal tissues: effect of cations and somatostatin analogues. Gut 34 1351-1356.
30. Munson PJ & Rodbard D 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding system. Analytical Biochemistry 107 220-239.
31. Palmer Smith J & Solomon TE 1988 Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 95 1541-1548.
32. Pan MG, Florio T & Stork PJS 1992 G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256 1215-1217.
33. Patel YC 1997 Molecular pharmacology of somatostatin receptor subtypes. Journal of Endocrinological Investigation 20 348-367.
34. Patel YC & Srikant CB 1997 Somatostatin receptors. Trends in Endocrinology and Metabolism 8 398-405.
35. Pawlikowski M, Zelazowski P & Stepien H 1989 Enhancement of human lymphocytes natural killer activity by somatostatin. Neuropeptides 13 75-77.
36. Pawlikowski M, Stepien H, Kunert-Radek J, Zelazowski P & Shally AV 1987 Immunomodulatory action of somatostatin. Annals of the New York Academy of Sciences 496 233-239.
37. Pollak MN & Schally AV 1998 Mechanism of antineoplastic action of somatostatin analogs. Proceedings of the Society for Experimental Biology and Medicine 217 143-152.
38. Qin Y, Shally AV & Willems G 1991 Somatostatin analogue RC-160 inhibits the growth of transplanted colon cancer in rats. International Journal of Cancer 47 765-770.
39. Qin Y, Shally AV & Willems G 1992 Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC-160. International Journal of Cancer 52 791-796.
40. Radulovic SS, Milovanovic SR, Cai RZ & Shally AV 1992 The binding of bombesin and somatostatin and their analogs to human colon cancers. Proceedings of the Society for Experimental Biology and Medicine 200 394-401.
41. Reubi JC, Horisberger U, Waser B, Gebbers JO & Laissue J 1992 Preferential location of somatostatin receptors in the germinal centers of human gut lymphoid tissue. Gastroenterology 103 1207-1214.
42. Reubi JC, Horisberger U & Laissue J 1994 High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction. International Journal of Cancer 56 681-688.
43. Reubi JC, Mazzucchelli L, Hennig I & Laissue JA 1996 Local up-regulation of neuropeptide receptors in host blood vessels around human colorectal cancers. Gastroenterology 110 1719-1726.
44. Ruszniewski P, Lehy T, Reyl-Desmars F, Le Roux S & Lewin MJM 1993 Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats. Regulatory Peptides 43 141-147.
45. Sharma K, Patel YC & Srikant CB 1996 Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Molecular Endocrinology 10 1688-1695.
46. Sharma K, Patel YC & Srikant CB 1999 C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G(1) cell cycle arrest. Molecular Endocrinology 13 82-90.
47. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD & Melmed S 1997 Somatostatin receptor subtype specificity in human fetal pituitary cultures: differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. Journal of Clinical Investigation 99 789-798.
48. Stewart GJ, Connor JL, Lawson JA, Preketes A, Kings J & Morris DL 1995 Octreotide reduces the kinetic index, proliferating cell nuclear antigen-maximum proliferative index, in patient with colorectal cancer. Cancer 76 572-578.
49. Thoss VS, Perez J, Probat A & Hover D 1996 Expression of five somatostatin receptor mRNA in the human brain and pituitary. Archives of Pharmacology 354 411-419.
50. Van Hagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, Anker-Lugtenburg PJ, Lowenberg B & Lamberts SWJ 1994 Somatostatin and the immune and haematopoietic system; a review. European Journal of Clinical Investigation 24 91-99.
51. Vuaroqueaux V, Dutour A, Briard N, Monges G, Grino M, Oliver C & Ouafik L'H 1999 No loss of sst receptors gene expression in advanced stages of colorectal cancer. European Journal of Endocrinology 140 362-366.
52. Warhurst G, Higgs NB, Grigor MR, Ross I & Barbezat GO 1995 Expression of multiple somatostatin receptor genes in human colonic epithelial cells. Biochemical Society Transactions 23 18S.
53. Warhurst G, Higgs NB, Fakoury H, Warhurst AC, Garde J & Coy DH 1996 Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon. Gastroenterology 111 325-333.